ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Christie, P.
Right arrow Articles by Lee, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Christie, P.
Right arrow Articles by Lee, T.
Eur Respir J 1994; 7: 907-913
Copyright © ERS Journals Ltd 1994

Original Articles

Increased urinary LTE4 excretion following inhalation of LTC4 and LTE4 in asthmatic subjects

PE Christie, P Tagari, AW Ford-Hutchinson, C Black, A Markendorf, M Schmitz-Schumann, and TH Lee

Urinary leukotriene E4 (LTE4) increases during exacerbations of asthma and following antigen challenge. We determined whether urinary LTE4 excretion reflects sulphidopeptide leukotrienes in the airways of asthmatic patients. Urinary LTE4 concentration was measured prior to and 1.5 and 3.5 h following inhalation of bronchoconstrictive doses of leukotriene C4 (LTC4) or LTE4 in eight asthmatic subjects. Increasing doses of agonist were inhaled until a 35% fall in specific airways conductance (sGaw) was achieved. There was no significant difference between the 53 +/- 3% (mean +/- SEM) fall in sGaw following inhalation of LTC4 (63.1 ng geometric mean, GM, range 5.8-527.5 ng) and the 43 +/- 4% fall in sGaw following inhalation of LTE4 7.94 ng/GM (range 132-3701 ng). The LTE4 excretion rate increased significantly from 2.95 (range 0.6-17.5) ng.h-1 to 4.67 (range 0.8-20) ng.h-1 at 1.5 h following LTC4 inhalation; and from 1.8 (range 0.07-6.7) ng.h-1 to 6.9 (range 2.9-27.3) ng.h-1 at 1.5 h following LTE4 inhalation; and had returned from baseline by 3.5 h. There was a correlation between the dose of LTC4 inhaled and LTE4 excreted in the urine (r = 0.82 and r = 0.72, respectively). The % recovery of LTE4 in the urine, of the total dose of inhaled LTC4 or LTE4 administered, was 6.9 +/- 4.1% and 0.8 +/- 0.3%, respectively. Thus, inhalation of bronchoconstricting doses of LTC4 or LTE4 alter urinary LTE4 excretion in a dose-dependent fashion. This indicates that urinary LTE4 can be used as a marker of sulphidopeptide leukotriene synthesis in the lungs of patients with asthma.


This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
T. J. Wetter, Z. Xiang, D. A. Sonetti, H. C. Haverkamp, A. J. Rice, A. A. Abbasi, K. C. Meyer, and J. A. Dempsey
Role of lung inflammatory mediators as a cause of exercise-induced arterial hypoxemia in young athletes
J Appl Physiol, July 1, 2002; 93(1): 116 - 126.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
A. J. MACFARLANE, R. DWORSKI, J. R. SHELLER, I. D. PAVORD, A. BARRY KAY, and N. C. BARNES
Sputum Cysteinyl Leukotrienes Increase 24 Hours after Allergen Inhalation in Atopic Asthmatics
Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1553 - 1558.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
M. KUMLIN
Measurement of Leukotrienes in Humans
Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): S102 - 106.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
J. M. DRAZEN
Leukotrienes as Mediators of Airway Obstruction
Am. J. Respir. Crit. Care Med., November 1, 1998; 158(2007): S193 - S200.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 by the European Respiratory Society.